Titan Biotech Ltd Financial Ratios
TITANBIOTECHLTD · Chemicals · Current price
P/E ratio
54.0x
P/B ratio
8.9x
ROE
17.8%
ROCE
23.0%
Debt / Equity
0.03
Dividend yield
0.5%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 54.0x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 8.9x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 17.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 23.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.03 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Titan Biotech Ltd's latest numbers.
Titan Biotech Ltd profitability
Titan Biotech Ltd generates a return on equity of 17.8% and a return on capital employed of 23.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.03 and a P/E of 54.0x, Titan Biotech Ltd is conservatively financed. Our overall business-quality score for the company is 5.3 / 10.
Understand the ratios
More on Titan Biotech Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.